Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Reduced ventilatory function and sarcopenia of the diaphragm muscle in a mouse model of advanced aging
Greising, Sarah M. , Sieck, Dylan C. , Mantilla, Carlos B. , Sieck, Gary C.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 26 | Issue: S1 | Pages: No page available

10.1096/fasebj.26.1_supplement.lb779 Get It

Aging is associated with respiratory complications and muscle dysfunction that may reduce the ability to perform expulsive, non‐ventilatory behaviors. We hypothesized that ventilatory function is impaired with aging and that the diaphragm muscle (DIAm) is susceptible to sarcopenia. Unrestrained‐awake ventilatory function, DIAm specific force, and fiber cross‐sectional area (CSA) were examined in a validated mouse model of advanced aging (expression of a hypomorphic allele ( H ) of BubR1 ), naturally aged (28 mo) and adult (5 mo) wild type ( wt ) mice (same genetic background). Minute ventilation and breathing frequency were decreased 17% in BubR1 H/H and 33% in aged wt mice vs. adult wt mice. Tidal volume was not different across groups. DIAm specific force was lower in both aged mice groups compared to the adult wt mice, being 62% lower in BubR1 H/H mice. DIAm fiber CSA from BubR1 H/H and aged wt mice was smaller than adult wt mice (23 and 10%, respectively). These results indicate that aging is associated with reduced ventilatory function and evidence of DIAm sarcopenia. In addition, aged mice recruit a greater percentage of DIAm fibers for eupneic breathing (greater fraction of maximum force). Together, these age‐related changes may limit the ability to accomplish expulsive, non‐ventilatory behaviors essential for airway clearance, and thus contribute to respiratory complications. Supported by Mayo Clinic.
The effects of acute β‐Adrenergic blockade on aortic wave reflection in post‐menopausal women
Wolhart, Sarah C., Charkoudian, Nisha , Hart, Emma C. , Barnes, Jill N. , Curry, Timothy B. , Joyner, Michael J. , Casey, Darren P.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 26 | Issue: S1 | Pages: No page available

10.1096/fasebj.26.1_supplement.lb628 Get It

Acute ß‐adrenergic blockade (BB) increases aortic wave reflection in young women, however, it is unknown if this effect extends to post‐menopausal women. Thus, we examined systemic BB on aortic wave reflection in 14 post‐menopausal women (58 ± 2 yr). Non‐invasive aortic pressure waveforms were synthesized from high‐fidelity radial pressure waveforms obtained from applanation tonometry before and during systemic BB (0.25mg/kg bolus, with 0.004 mg/kg/min continuous infusion of propranolol). Aortic blood pressure, augmentation index (AIx), AIx adjusted for heart rate (AIx@75), aortic augmented pressure (AP), and wasted left ventricular energy (Ew) were calculated from the aortic pressure waveform. Heart rate (60 ± 2 vs. 51 ± 2 bpm) and mean arterial pressure (95 ± 3 vs. 91 ± 3 mmHg) were reduced with BB (P < 0.05 for both). AIx increased during BB (32 ± 2 vs. 35 ± 2%, P < 0.01), however, AIx@75 was unchanged (25 ± 2 vs. 24 ± 2%, ns). Additionally, AP (20 ± 2 vs. 20 ± 2 mmHg, ns) and Ew (4313 ± 538 vs. 4277 ± 537 dyne*cm2/sec, ns) remained unchanged during BB. When compared to our previously published study in young women, indices of aortic wave reflection were significantly less affected in post‐menopausal women in response to acute systemic BB. Taken together, our data suggest that the negative effects (i.e. increased aortic wave reflection) of non‐selective BB are less pronounced in post‐menopausal women.
Heart rate variability is altered by dietary sodium: a randomized cross‐over study in healthy young adults
Allen, Alexander R., Gullixson, Leah R., Wolhart, Sarah C., Kost, Susan L., Eisenach, John H., Schroeder, Darrell R.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.695.17 Get It

Dietary sodium influences intermediate physiological traits in healthy young adults independent of changes in blood pressure. The purpose of this study was to test the hypothesis that dietary sodium affects cardiac autonomic function. In prospective, randomized cross‐over design separated by 1 month or more between diets, 69 normotensive healthy young adults (M/F: 26/43, ages 18–38 yr) consumed a 5‐day low (10 mmol/day), normal (150 mmol), and high sodium (400mmol) diet prior to a protocol examining cardiovascular traits including heart rate variability (HRV) by time domain and frequency domain analysis (Nevrokard). All women were studied in the low hormone phase of the menstrual cycle. Diet did not affect blood pressure, but HR (mean ± SE) was 68±1, 65±1, and 64±1 in low, normal, and high sodium conditions, resp. (RM ANOVA p < 0.01). For HRV there was a main effect of sodium on SDNN, RMSSD, HF, LFnu, HFnu, and LF/HF ratio (p < 0.01 for all). The response to low sodium was most marked and consistent with sympathetic activation, with increased LFnu and LF/HF ratio, and decreased SDNN, RMSSD, and HFnu compared to both normal and high sodium conditions (p ≤ 0.05 for all). These findings suggest that autonomic control of HRV is altered through changes in dietary sodium without changes in blood pressure. Support: UL1 TR000135 , HL‐89331
Cardiovascular Response to an Inhaled β‐Agonist in Patients with Heart failure, Effect of β‐Blockade
Martínez, Marina González, Johnson, Bruce D. , Snyder, Eric M., Baker, Sarah E. , Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1126.5 Get It

Asthma, chronic obstructive pulmonary disease, and other respiratory disorders often occur concurrently with heart failure (HF). HF patients with respiratory disease can improve lung function and, therefore, quality of life with β‐agonists. Beta‐agonist use remains controversial as it has been linked with increased mortality risk; however, recent studies that account for co‐morbidities find no association between β‐agonist use and mortality. Previous studies exploring the cardiovascular effect of β‐agonist use in HF are primarily retrospective and focus on heart rate (HR). We have previously demonstrated altered cardiovascular function in response to albuterol in healthy subjects. In the present study we sought to comprehensively assess the cardiovascular effects of albuterol sulfate using cardiac output (Q), stroke volume (SV), HR, systolic, diastolic, and mean arterial blood pressure (SBP, DBP, MAP, respectively) and systemic vascular resistance (SVR). We hypothesized that cardiovascular parameters would be altered 30‐minutes following albuterol administration, and that HF patients using β‐blockers would have an attenuated response. Twenty‐two healthy and twenty‐two HF subjects were recruited (age=56±13 vs. 62±12yrs; height=175±10 vs. 176±9cm; weight=78±15 vs. 93±20; BMI=26±4 vs. 30±6; and BSA=2.08±0 vs. 1.93±0m 2 , for healthy and HF, respectively, p<0.05 for weight, BMI, and BSA). We found that HR and Q increased in healthy but not HF subjects at 30min following albuterol. Patients who were not on β‐blockers (n=4, 18%) had an increase in SV and a decrease in SVR with albuterol, while there was no change in patients who were on β‐blockers (n=14, 64%). These data suggest that HF patients have an attenuated cardiovascular response to inhaled albuterol, particularly with concurrent β‐blocker usage.
Dexmedetomidine Levels in Breast Milk: Analysis of Breast Milk Expressed During and After Awake Craniotomy
Dodd, Sarah E. , Guevara, Lindsay R. Hunter, Datta, Palika , Rewers‐Felkins, Kathleen, Baker, Teresa, Hale, Thomas W. , Hunter Guevara, Lindsay R

Mayo Clinic

Breastfeeding Medicine | June 18, 2021 | Volume: 16 | Issue: 11 | Pages: 919-921

10.1089/bfm.2021.0138 | PMID 34143658 Get It

Transdiaphragmatic pressure measurements reveal age‐related diaphragm muscle dysfunction during non‐ventilatory behaviors
Greising, Sarah M. , Mantilla, Carlos B. , Sieck, Dylan C. , Sieck, Gary C.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.719.7 Get It

The diaphragm muscle (DIAm) is responsible for breathing and must provide sufficient force to accomplish both ventilatory and non‐ventilatory behaviors. Age‐related changes to the DIAm, especially sarcopenia, may limit the ability to accomplish expulsive, non‐ventilatory behaviors essential for airway clearance, and thus contribute to respiratory complications. Age‐related changes in load (as a result of chest wall stiffening or lung compliance) may impact DIAm function. Adult male mice (6 and 24 months old) underwent measurements of respiratory system compliance and transdiaphragmatic pressure (Pdi) during: eupnea, hypoxia (10% O 2 ) –hypercapnia (5% CO 2 ), spontaneously occurring deep breaths, airway occlusion, and bilateral phrenic nerve stimulation. Overall respiratory system compliance decreased with age (increased load), while Pdi required for ventilatory behaviors did not change, consistent with the reserve capacity of the DIAm. The Pdi generated during deep breaths and airway occlusion were reduced 30–45% with age. These results indicate that DIAm dysfunction during aging is associated with reduced force to perform expulsive, non‐ventilatory behaviors. Reduced reserve capacity in old age may underlie increased susceptibility to lung infections and augment respiratory compromise associated with other age‐related diseases. Supported by T32‐HL‐105355 and the Mayo Clinic.
Influence of Inhaled Amiloride on Lung Fluid Regulation During Normobaric Hypoxia in Healthy Humans
Wheatley, Courtney M. , Kasak, A., Carlson, Alex R. , Hulsebus, Minelle L., Snyder, Eric M., Johnson, Bruce D., Baker, Sarah E. , Miller, Andrew D, Kasak, Alexander J, Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.715.9 Get It

Background Fluid flux in the lungs is influenced by factors altering accumulation or removal (e.g., stimulation of epithelium sodium channels, ENaC). Purpose To determine if ENaC are necessary in the normal fluid regulation with simulated altitude exposure. Methods/Results On separate occasions, 19 healthy subjects (27 ± 5 y) received either nebulized amiloride (ENaC antagonist) or placebo (nebulized saline) during 17 h normobaric hypoxia (FIO2 = 12.5%) in a randomized, double‐blind fashion. Lung diffusing capacity for carbon monoxide (DLCO), alveolar‐capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) were measured via a rebreathe method before and after hypoxic exposure. DLCO was not different at baseline for the amiloride vs. placebo treatments (19 ± 5 vs. 21 ± 8 mL/min/mmHg). Hypoxic exposure increased Vc but did not change Dm in both treatments (Placebo: Vc = 43 ± 22 vs. 59±23 mL p=0.011, Dm = 35 ± 10 vs. 37 ± 12 mL/min/mmHg p=0.312; Amiloride: Vc = 38 ± 17 vs. 57 ± 22 mL p<0.01, Dm = 31 ± 8 vs. 34 ± 10 mL/min/mmHg p= 0.206). Conclusion Normobaric hypoxia did not differentially affect alveolar‐capillary conductance in amiloride and placebo conditions, suggesting that ENaC do not have a role in normal lung fluid regulation during acute hypoxic exposure. HL71478
Age‐related differences in carotid and cerebral blood flow regulation (1069.4)
Kruse, Sarah, Ranadive, Sushant M. , Taylor, Jennifer L. , Joyner, Michael J. , Barnes, Jill N.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 28 | Issue: S1 | Pages: No page available

10.1096/fasebj.28.1_supplement.1069.4 Get It

Common carotid artery (CA) and middle cerebral artery (MCA) blood flow are controlled by multiple factors to ensure that the brain receives adequate blood supply. Additionally, CA arterial stiffness may affect blood flow regulation. The purpose of this study was to investigate the effect of cyclooxygenase (COX) inhibition on arterial stiffness and the relationship between CA and MCA blood flow in young (26±5y) and older (66±7y) adults to determine if aging modifies this relationship. While baseline CA flow and flow velocity were similar between groups, baseline MCA flow velocity was greater in young (59±6 cm/s) compared to older (40±4 cm/s) adults (p<0.05). During COX inhibition, CA flow, CA flow velocity and MCA flow velocity decreased from baseline in young (∆: ‐116±35 mL/min, ‐6±1 cm/s, ‐23±5 cm/s; respectively) and older adults (∆: ‐153±40 mL/min, ‐5±1 cm/s, ‐11±2 cm/s; respectively). The association between CA flow velocity and MCA flow velocity was altered by COX inhibition (r=0.60 vs. r=0.15). β‐stiffness was higher in older compared to young adults (13±2 vs. 5±1 AU; p<0.05). Among older adults, there was a trend for COX inhibition to increase β‐stiffness. Our results suggest that CA and MCA blood flow are regulated differently and that COX inhibition alters the correlation between CA and MCA blood flow. Therefore, it may be incorrect to assume that CA flow is a surrogate measurement for cerebral blood flow.